1. Home
  2. CENTA vs SRPT Comparison

CENTA vs SRPT Comparison

Compare CENTA & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company Nonvoting

CENTA

Central Garden & Pet Company Nonvoting

HOLD

Current Price

$38.45

Market Cap

2.3B

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$15.68

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENTA
SRPT
Founded
1955
1980
Country
United States
United States
Employees
6000
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
CENTA
SRPT
Price
$38.45
$15.68
Analyst Decision
Hold
Hold
Analyst Count
4
29
Target Price
$36.75
$25.85
AVG Volume (30 Days)
341.6K
3.6M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
N/A
$2,198,237,000.00
Revenue This Year
$1.60
N/A
Revenue Next Year
$2.04
N/A
P/E Ratio
$13.52
$5.51
Revenue Growth
N/A
15.58
52 Week Low
$25.97
$11.68
52 Week High
$39.99
$25.32

Technical Indicators

Market Signals
Indicator
CENTA
SRPT
Relative Strength Index (RSI) 54.17 35.98
Support Level $36.52 $15.55
Resistance Level $39.99 $18.16
Average True Range (ATR) 1.30 0.93
MACD -0.10 -0.35
Stochastic Oscillator 46.22 5.96

Price Performance

Historical Comparison
CENTA
SRPT

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: